Clinical Trial Update: Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates report studying pentoxifylline as an adjunctive treatment for negative symptoms in chronic schizophrenia (Phase 1/Phase 2 completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Sadat City University | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED